引用本文:严志祎1,焦海燕1,马庆宇1,李晓娟1,潘秋霞1,王亭晔1,侯雅静1,王方方1,刘玥芸1,陈家旭1,岳利峰2.基于分子机制的逍遥散方证相关研究思路[J].世界中医药,2017,(03):. |
|
基于分子机制的逍遥散方证相关研究思路 |
Discussion on molecular mechanism in correlation between prescription and syndrome of Xiaoyaosan |
投稿时间:2017-02-20 |
DOI:10.3969/j.issn.1673-7202.2017.03.002 |
中文关键词: 肝郁脾虚证 逍遥散 方正相关 分子机制 |
English Keywords:Syndrome of stagnation of liver qi and spleen deficiency Xiaoyaosan Correlation between prescription and syndrome Molecular mechanism |
基金项目:国家自然科学基金面上项目(编号:81473597);国家自然科学基金重点项目(编号:81630104);国家自然科学基金青年项目(编号:81302960) |
|
摘要点击次数: 1096 |
全文下载次数: 1325 |
中文摘要: |
逍遥散作为疏肝健脾的经典方剂,在临床上广泛应用于治疗各科疾病所涉及的肝郁脾虚证之中,长久以来也进行了大量关于逍遥散调节作用与肝郁脾虚证发病机制内在联系与规律的研究。文章从分子机制研究的侧面着手,探讨了逍遥散方证研究的思路,以期为今后包括逍遥散与肝郁脾虚证在内的方证研究提供思路与方法。 |
English Summary: |
Xiaoyaosan is the classic prescription of soothing the liver and invigorating the spleen, which is widely used in clinical departments, especially syndrome of stagnation of liver qi and spleen deficiency. For long times, there is a lot of researches about the inner link between the regulating effect of Xiaoyaosan and the mechanism of syndrome of liver depression and spleen deficiency. This paper starts from the molecular mechanism, and discusses the thought in prescription and syndrome of Xiaoyaosan, hoping to provide the thinking and method to the study of prescription and syndrome including Xiaoyaosan and syndrome of stagnation of liver qi and spleen deficiency. |
查看全文 查看/发表评论 下载PDF阅读器 |